On November 13, innovative drug concept stocks exhibited fluctuating activity, with Nanjing Xinjiekou Department Store Co., Ltd. (600682) securing two consecutive trading limit-ups. BeiGene (BGNE) rose over 6%, while Haisco Pharmaceutical Group (300584), Lianhe Chemical Technology (002250), Wanzhou Pharmaceutical (000534), and Salubris (002294) followed with gains.